Carl Lenarsky

3.4k total citations
54 papers, 1.9k citations indexed

About

Carl Lenarsky is a scholar working on Hematology, Molecular Biology and Neurology. According to data from OpenAlex, Carl Lenarsky has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 11 papers in Molecular Biology and 11 papers in Neurology. Recurrent topics in Carl Lenarsky's work include Hematopoietic Stem Cell Transplantation (23 papers), Neuroblastoma Research and Treatments (10 papers) and Acute Lymphoblastic Leukemia research (6 papers). Carl Lenarsky is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Neuroblastoma Research and Treatments (10 papers) and Acute Lymphoblastic Leukemia research (6 papers). Carl Lenarsky collaborates with scholars based in United States, Switzerland and Canada. Carl Lenarsky's co-authors include Robertson Parkman, Kenneth I. Weinberg, Stephen A. Feig, Donald B. Kohn, W. G. Ho, Michael T. Selch, Robert Elashoff, Richard E. Champlin, Ronald T. Mitsuyasu and D. J. Winston and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Carl Lenarsky

54 papers receiving 1.9k citations

Peers

Carl Lenarsky

HEMAT

IMMUN

ONCOL

GENET

Fumio Bessho Japan

Anna Porwit‐MacDonald Sweden

Masue Imaizumi Japan

W. Lange Germany

Juan Ortega Spain

Emmanuel Plouvier France

Shin Fujisawa Japan

João L. Ascensão United States

Hans Hägglund Sweden

Mathias Schmid Germany

Fumio Bessho Japan

Carl Lenarsky

1.1k ×1.3

HEMAT

230 ×0.5

IMMUN

863 ×2.2

357 ×1.1

ONCOL

286 ×0.9

GENET

Citations per year, relative to Carl Lenarsky Carl Lenarsky (= 1×) peers Fumio Bessho

Countries citing papers authored by Carl Lenarsky

Since Specialization

Citations

This map shows the geographic impact of Carl Lenarsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Lenarsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Lenarsky more than expected).

Fields of papers citing papers by Carl Lenarsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Lenarsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Lenarsky. The network helps show where Carl Lenarsky may publish in the future.

Co-authorship network of co-authors of Carl Lenarsky

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Lenarsky. A scholar is included among the top collaborators of Carl Lenarsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Lenarsky. Carl Lenarsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barve, Minal, Reva Schneider, Robert Mennel, et al.. (2015). Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma. Molecular Therapy. 23(6). 1103–1109. 48 indexed citations

Shah, Ami J., Neena Kapoor, Robert Cooper, et al.. (2008). Pre‐ and post‐natal treatment of hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer. 52(1). 139–142. 10 indexed citations

Shah, Ami J., Carl Lenarsky, Neena Kapoor, et al.. (2004). Busulfan and Cyclophosphamide as a Conditioning Regimen for Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Bone Marrow Transplantation. Journal of Pediatric Hematology/Oncology. 26(2). 91–97. 18 indexed citations

Shah, Ami J., Neena Kapoor, Kenneth I. Weinberg, et al.. (2002). Second hematopoietic stem cell transplantation in pediatric patients: Overall survival and long-term follow-up. Biology of Blood and Marrow Transplantation. 8(4). 221–228. 15 indexed citations

Goldman, Stanton, Francisco Bracho, Virginia Davenport, et al.. (2001). Feasibility Study of IL-11 and Granulocyte Colony-Stimulating Factor After Myelosuppressive Chemotherapy to Mobilize Peripheral Blood Stem Cells From Heavily Pretreated Patients. The American journal of pediatric hematology/oncology. 23(5). 300–305. 11 indexed citations

Lenarsky, Carl, et al.. (2000). Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy. Bone Marrow Transplantation. 25(12). 1311–1313. 7 indexed citations

Crooks, GM, et al.. (1995). Bone Marrow Transplantation for Metabolic Diseases. Cancer treatment and research. 76. 87–96. 6 indexed citations

Lenarsky, Carl. (1995). Immune recovery after bone marrow transplantation. Current Opinion in Hematology. 2(6). 409–412. 8 indexed citations

Weinberg, Kenneth I., M S Hershfield, John F. Bastian, et al.. (1993). T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.. Journal of Clinical Investigation. 92(2). 596–602. 46 indexed citations

10.

Lenarsky, Carl. (1993). Mechanisms in Immune Recovery After Bone Marrow Transplantation. Journal of Pediatric Hematology/Oncology. 15(1). 49–55. 19 indexed citations

11.

Finklestein, Jerry Z., Mark Krailo, Carl Lenarsky, et al.. (1992). 13‐cis‐retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the childrens cancer study group. Medical and Pediatric Oncology. 20(4). 307–311. 72 indexed citations

12.

Özkaynak, M. Fevzi, et al.. (1991). Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.. PubMed. 7(6). 467–74. 58 indexed citations

13.

Özkaynak, M. Fevzi, Carl Lenarsky, Donald B. Kohn, Kenneth I. Weinberg, & Robertson Parkman. (1990). Mycobacterium Av/wm-Intracellulare Infections After Allogeneic Bone Marrow Transplantation in Children. Journal of Pediatric Hematology/Oncology. 12(1). 220–224. 12 indexed citations

14.

Lenarsky, Carl, Donald B. Kohn, Kenneth I. Weinberg, & Robertson Parkman. (1990). Bone Marrow Transplantation for Genetic Diseases. Hematology/Oncology Clinics of North America. 4(3). 589–602. 15 indexed citations

15.

Moss, Thomas J., Eric W. Fonkalsrud, Stephen A. Feig, et al.. (1987). Delayed Surgery and Bone Marrow Transplantation for Widespread Neuroblastoma. Annals of Surgery. 206(4). 514–520. 16 indexed citations

16.

Kangarloo, Hooshang, et al.. (1987). Neuroblastoma: the role of MR imaging. American Journal of Roentgenology. 148(5). 937–942. 46 indexed citations

17.

Gj, D'Angio, Evans Ae, R C Seeger, et al.. (1985). Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.. PubMed. 175. 557–63. 21 indexed citations

18.

Lenarsky, Carl, D. Alan Shewmon, Anthony Shaw, & Stephen A. Feig. (1985). Occurrence of neuroblastoma and asymmetric crying facies: Case report and review of the literature. The Journal of Pediatrics. 107(2). 268–270. 6 indexed citations

19.

Bayever, Eliel, Richard E. Champlin, Winston G. Ho, et al.. (1984). Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. The Journal of Pediatrics. 105(6). 920–925. 40 indexed citations

20.

Berant, Moshe, et al.. (1978). Cold weather and rhabdomyolysis. The Journal of Pediatrics. 93(6). 970–971. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact